AAI Asks 8th Circ. To Revive FTC Drug Monopoly Suit
Docketed in the U.S. Court of Appeals for the Eight Circuit on Thursday, the AAI's brief says that the lower court ignored nonprice competition and misapplied fundamental principles of market definition.
The district court's dismissal rests on the view that the cross-price elasticity, or the percentage change...
To view the full article, register now.